Source: StreetInsider

Press Release: Lungpacer : Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace System

EXTON, Pa., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace System, a next generation product, into the...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Doug Evans's photo - President & CEO of Lungpacer

President & CEO

Doug Evans

CEO Approval Rating

90/100

Read more